Skip to main content
NCBI home page
Clinical Molecular Pathology logoLink to Clinical Molecular Pathology
. 1996 Jun;49(3):M180–M181. doi: 10.1136/mp.49.3.m180

Postmortem diagnosis of Factor V Leiden from paraffin wax embedded tissue

J S Webb 1,2, G R Standen 1,2, C M P Collins 1,2, C P Case 1,2
PMCID: PMC408048  PMID: 16696070

Abstract

Activated protein C resistance resulting from Factor V Leiden is an important inherited thrombophilia disorder which is found in 3.5% of people in the UK. The genetic defect can be detected using the PCR and the diagnosis can be made postmortem from paraffin wax embedded tissue. The presence of Factor V Leiden should be sought in all cases of unexplained sudden death resulting from venous thromboembolism.

Keywords: Factor V Leiden

Keywords: thromboembolism

Keywords: thrombophilia disorder

Full text

PDF
M180

Images in this article

M180Image
on p.M180
M181Image
on p.M181

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beauchamp N. J., Daly M. E., Hampton K. K., Cooper P. C., Preston F. E., Peake I. R. High prevalence of a mutation in the factor V gene within the U.K. population: relationship to activated protein C resistance and familial thrombosis. Br J Haematol. 1994 Sep;88(1):219–222. doi: 10.1111/j.1365-2141.1994.tb05005.x. [DOI] [PubMed] [Google Scholar]
  2. Bertina R. M., Koeleman B. P., Koster T., Rosendaal F. R., Dirven R. J., de Ronde H., van der Velden P. A., Reitsma P. H. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature. 1994 May 5;369(6475):64–67. doi: 10.1038/369064a0. [DOI] [PubMed] [Google Scholar]
  3. Dahlbäck B., Carlsson M., Svensson P. J. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci U S A. 1993 Feb 1;90(3):1004–1008. doi: 10.1073/pnas.90.3.1004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Dahlbäck B. Inherited thrombophilia: resistance to activated protein C as a pathogenic factor of venous thromboembolism. Blood. 1995 Feb 1;85(3):607–614. [PubMed] [Google Scholar]
  5. De Stefano V., Mastrangelo S., Paciaroni K., Ireland H., Lane D. A., Scirpa P., Bizzi B., Leone G. Thrombotic risk during pregnancy and puerperium in women with APC-resistance--effective subcutaneous heparin prophylaxis in a pregnant patient. Thromb Haemost. 1995 Aug;74(2):793–794. [PubMed] [Google Scholar]
  6. Heeb M. J., Kojima Y., Greengard J. S., Griffin J. H. Activated protein C resistance: molecular mechanisms based on studies using purified Gln506-factor V. Blood. 1995 Jun 15;85(12):3405–3411. [PubMed] [Google Scholar]
  7. Koeleman B. P., van Rumpt D., Hamulyák K., Reitsma P. H., Bertina R. M. Factor V Leiden: an additional risk factor for thrombosis in protein S deficient families? Thromb Haemost. 1995 Aug;74(2):580–583. [PubMed] [Google Scholar]
  8. Lang J., Price A. B., Levi A. J., Burke M., Gumpel J. M., Bjarnason I. Diaphragm disease: pathology of disease of the small intestine induced by non-steroidal anti-inflammatory drugs. J Clin Pathol. 1988 May;41(5):516–526. doi: 10.1136/jcp.41.5.516. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Rosendaal F. R., Koster T., Vandenbroucke J. P., Reitsma P. H. High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance) Blood. 1995 Mar 15;85(6):1504–1508. [PubMed] [Google Scholar]
  10. Vandenbroucke J. P., Koster T., Briët E., Reitsma P. H., Bertina R. M., Rosendaal F. R. Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation. Lancet. 1994 Nov 26;344(8935):1453–1457. doi: 10.1016/s0140-6736(94)90286-0. [DOI] [PubMed] [Google Scholar]

Articles from Clinical Molecular Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES